Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,785,928
  • Shares Outstanding, K 146,796
  • Annual Sales, $ 4,685 M
  • Annual Income, $ 1,021 M
  • EBIT $ 1,464 M
  • EBITDA $ 1,680 M
  • 60-Month Beta 0.69
  • Price/Sales 7.63
  • Price/Cash Flow 26.40
  • Price/Book 6.88

Options Overview Details

View History
  • Implied Volatility 29.41% ( +0.06%)
  • Historical Volatility 30.15%
  • IV Percentile 28%
  • IV Rank 17.97%
  • IV High 63.20% on 08/01/24
  • IV Low 22.00% on 05/09/24
  • Put/Call Vol Ratio 3.17
  • Today's Volume 25
  • Volume Avg (30-Day) 546
  • Put/Call OI Ratio 3.10
  • Today's Open Interest 28,413
  • Open Int (30-Day) 30,586

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.25
  • Number of Estimates 4
  • High Estimate 2.28
  • Low Estimate 2.21
  • Prior Year 1.88
  • Growth Rate Est. (year over year) +19.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
231.17 +6.08%
on 11/15/24
259.33 -5.44%
on 10/28/24
-10.85 (-4.24%)
since 10/25/24
3-Month
224.75 +9.11%
on 08/26/24
260.49 -5.86%
on 10/25/24
+18.59 (+8.20%)
since 08/23/24
52-Week
151.95 +61.39%
on 11/28/23
260.49 -5.86%
on 10/25/24
+91.35 (+59.36%)
since 11/24/23

Most Recent Stories

More News
ResMed Stock: Is Wall Street Bullish or Bearish?

Although ResMed has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

XLV : 145.60 (+1.00%)
$SPX : 5,997.34 (+0.47%)
RMD : 246.35 (+1.05%)
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...

DGX : 165.07 (+0.90%)
BSX : 88.35 (-1.83%)
RMD : 246.35 (+1.05%)
ALC : 85.82 (-0.20%)
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030

/CNW/ -- Recently the World Economic Forum released a report that highlights AI's potential to relieve pressure on healthcare systems worldwide, with Mayo...

MSFT : 415.35 (-0.40%)
AIDX.TO : 1.51 (-3.21%)
HWAIF : 1.1000 (+0.92%)
NVDA : 137.19 (-3.35%)
AVAI : 0.5300 (+6.00%)
WELL.TO : 5.23 (+1.16%)
RMD.AX : 37.560 (+0.75%)
RMD : 246.35 (+1.05%)
WHTCF : 3.7350 (+0.40%)
CLOV : 3.48 (+3.26%)
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...

ZBH : 111.23 (+0.92%)
GMED : 84.69 (-0.04%)
BSX : 88.35 (-1.83%)
RMD : 246.35 (+1.05%)
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...

DGX : 165.07 (+0.90%)
BSX : 88.35 (-1.83%)
BDX : 224.65 (+0.29%)
RMD : 246.35 (+1.05%)
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Catalent, Inc. CTLT reported first-quarter fiscal 2025 adjusted loss per share of 13 cents, flat year over year. The figure was wider than the Zacks Consensus Estimate of a loss of 11 cents per share....

DGX : 165.07 (+0.90%)
BSX : 88.35 (-1.83%)
CTLT : 61.11 (+0.21%)
RMD : 246.35 (+1.05%)
ResMed Announces Participation in the UBS Global Healthcare Conference

RMD.AX : 37.560 (+0.75%)
RMD : 246.35 (+1.05%)
Insulet Stock Gains From Expansion Strategies, Innovation

Insulet’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on the significant growth opportunities in the Type 2 diabetes space. PODD carries...

GMED : 84.69 (-0.04%)
BSX : 88.35 (-1.83%)
RMD : 246.35 (+1.05%)
PODD : 265.94 (+1.14%)
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2025 were $2.20, up 34.1% year over year. The metric beat the Zacks Consensus Estimate by 8.4%.The adjustments include...

DGX : 165.07 (+0.90%)
BSX : 88.35 (-1.83%)
RMD : 246.35 (+1.05%)
ISRG : 541.83 (-1.10%)
My 3 Favorite Stocks to Buy Right Now

Here are three attractive stocks to buy that will give you a healthy mix of growth and dividends.

RMD : 246.35 (+1.05%)
TSCO : 286.43 (+2.07%)
LII : 672.79 (+2.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 247.07
2nd Resistance Point 245.48
1st Resistance Point 244.63
Last Price 246.35
1st Support Level 242.19
2nd Support Level 240.59
3rd Support Level 239.74

See More

52-Week High 260.49
Last Price 246.35
Fibonacci 61.8% 219.03
Fibonacci 50% 206.22
Fibonacci 38.2% 193.41
52-Week Low 151.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar